CVE:LTY

Liberty Biopharma - LTY Stock Forecast, Price & News

C$2.00

+2.00 (+∞)

(As of 10/10/2018)

Add

Compare

Today's Range: C$2.00
▼
C$2.00
50-Day Range: C$2.00
▼
C$2.00
52-Week Range: C$0.06
▼
C$2.74

Volume: 700 shs
Average Volume: 23,286 shs
Market Capitalization: C$21.54 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Liberty Biopharma (CVE:LTY) Stock

Liberty Biopharma Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease. The company was formerly known as Avagenesis Corp. and changed its name to Liberty Biopharma Inc. in January 2017. Liberty Biopharma Inc. is based in Richmond, Canada.

Receive LTY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Liberty Biopharma and its competitors with MarketBeat's FREE daily newsletter.

LTY Stock News Headlines

January 27, 2023 | bizjournals.com

Sale price leaps by $20M for repurposed Durham warehouse

November 1, 2022 | msn.com

How a Maryland ‘Moms for Liberty' group became leaders in our country's culture war

February 1, 2023 | Investing Trends (Ad)

Move Over Lithium – 220 Pounds of Graphite In Every EV Battery

Investors constantly hear that lithium is the key to powering our transition to electric vehicles and clean energy. Truth is, switching from gas-powered isn't possible without massive amounts of graphite. But America hasn't produced any graphite since the 1950s. Now, a little-known exploration company has defined America's largest high-quality graphite deposit near Nome, Alaska.

October 24, 2022 | msn.com

Liberty Oilfield Services (LBRT) Is Attractively Priced Despite Fast-paced Momentum

October 19, 2022 | benzinga.com

Liberty Energy Inc. Announces Third Quarter 2022 Financial and Operational Results

October 17, 2022 | technews.tmcnet.com

Liberty Announces Overnight Marketed Public Offering of Units

September 30, 2022 | technews.tmcnet.com

Liberty Defense to Beta Test HEXWAVE System with Top US Airline

September 24, 2022 | markets.businessinsider.com

Liberty Advisor Group Named One of 2022 Best Places to Work in Chicago

February 1, 2023 | Investing Trends (Ad)

Move Over Lithium – 220 Pounds of Graphite In Every EV Battery

September 24, 2022 | investing.com

Liberty Two Degrees (L2DJ)

September 21, 2022 | seekingalpha.com

Liberty Energy Is Working To Complete Turnaround Strategy

September 9, 2022 | investing.com

Liberty Financial Group Pty Ltd (LFG)

September 8, 2022 | investing.com

Liberty Shoes Ltd (LIBS)

September 7, 2022 | nasdaq.com

Liberty Latin America Ltd - Class C Shares Fall 1.0% Below Previous 52-Week Low - Market Mover

September 2, 2022 | apnews.com

Myovant Sciences to Participate at Upcoming Investor Conferences

September 1, 2022 | apnews.com

Liberty HealthShare Launches Liberty Rise Sharing Program for Young Adults

August 29, 2022 | finance.yahoo.com

Earnings Estimates Moving Higher for Liberty Oilfield Services (LBRT): Time to Buy?

August 24, 2022 | finance.yahoo.com

How Much Upside is Left in Liberty Oilfield Services (LBRT)? Wall Street Analysts Think 33%

August 24, 2022 | bizjournals.com

Liberty Diversified names new president, CEO

August 15, 2022 | markets.businessinsider.com

Liberty Bankers Insurance Group Increases Lump Sum Benefit for Critical Illness Product

March 6, 2022 | ca.finance.yahoo.com

UPDATE 1-Russia curbs access to BBC Russian service and Radio Liberty

February 28, 2022 | finance.yahoo.com

DMG Bancshares, Inc. to Acquire Liberty Bancorp

January 2, 2022 | finance.yahoo.com

Letters to the editor for Friday, Dec. 31: Here's to a plant-based new year

November 17, 2021 | au.finance.yahoo.com

England urged to call out Qatar’s record on human rights during 2022 World Cup by Amnesty International

September 8, 2021 | au.finance.yahoo.com

Major U.S. insurers jump on distribution platforms to gain customers, sales

July 31, 2021 | ca.finance.yahoo.com

Liberty Expands to the Boston Area to Accelerate Company Growth

July 16, 2021 | au.finance.yahoo.com

Iraqi cleric Sadr says he won't take part in October election

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive LTY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Liberty Biopharma and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: CVE
Industry: Biotechnology
Sub-Industry: N/A
Sector: Medical
Current Symbol: CVE:LTY
Previous Symbol: CVE:VVA
CUSIP: N/A
CIK: N/A
Web: www.libertybiopharma.com
Phone: +1-604-3777575
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 8.19
Current Ratio: 0.12
Quick Ratio: 0.12

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: C$0.00 per share
Price / Cash Flow: 2,000.00
Book Value: C$0.79 per share
Price / Book: 2.53

Miscellaneous

Outstanding Shares: 10,770,000
Free Float: N/A
Market Cap: C$21.54 million
Optionable: Not Optionable
Beta: N/A

Key Executives

Mr. Norman Tsui (Age 45)
Pres, CEO & Director

Mr. Shui Yan Tam (Age 44)
Chief Financial Officer

Dr. Michael T. McNamara
Medical Advisor & Director

Dr. Richard Huang Ph.D. (Age 42)
Chief Technology Officer

Dr. Richard Cook M.D.
Msc., FRCSC, Chief Medical Officer

Key Competitors

View All Competitors

LTY Stock - Frequently Asked Questions

How have LTY shares performed in 2023?: Liberty Biopharma's stock was trading at C$2.00 at the beginning of 2023. Since then, LTY stock has increased by 0.0% and is now trading at C$2.00.
View the best growth stocks for 2023 here.
What other stocks do shareholders of Liberty Biopharma own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Liberty Biopharma investors own include Cross Timbers Royalty Trust (CRT), InfraCap MLP ETF (AMZA), Alliance Resource Partners (ARLP), Brigham Minerals (MNRL), Arbor Realty Trust (ABR), Advanced Emissions Solutions (ADES), Archer-Daniels-Midland (ADM), AGNC Investment (AGNC) and AMC Entertainment (AMC).

What is Liberty Biopharma's stock symbol?: Liberty Biopharma trades on the Canadian Venture Exchange (CVE) under the ticker symbol "LTY."
How do I buy shares of Liberty Biopharma?: Shares of LTY stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.
What is Liberty Biopharma's stock price today?: One share of LTY stock can currently be purchased for approximately C$2.00.
How much money does Liberty Biopharma make?: Liberty Biopharma (CVE:LTY) has a market capitalization of C$21.54 million.
How can I contact Liberty Biopharma?: Liberty Biopharma's mailing address is 2270-8788 McKim Way, RICHMOND, BC V6X 4E2, Canada. The official website for the company is www.libertybiopharma.com. The biotechnology company can be reached via phone at +1-604-3777575.

This page (CVE:LTY) was last updated on 2/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial